IRCT2015103024792N1
Completed
Phase 2
To determine the effect of Oxytocin in compared with placebo on craving; withdrawal and stress response in heroin dependents.
Vice chancellor for research Kashan University of Medical Sciences0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Condition 1: Withdrawal syndrome. Condition 2: Craving.
- Sponsor
- Vice chancellor for research Kashan University of Medical Sciences
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects must meet DSM\-IV criteria for current heroin dependence ( within the past six months). Subjects must be at the beginning of treatment period and must abstain from heroin for at least three days prior to testing. patients willing to participate in the intervention\- The age range of subjects must be between 20 to 60 years old. Subjects must be literate.
- •Exclusion Criteria :
- •Women who are pregnant, nursing or of childbearing potential and positive of pregnancy test. Subjects with evidence of or a history of significant hematological, endocrine, cardiovascular, pulmonary, renal, drug allergy or neurological disease including diabetes, as these conditions may affect physiological/subjective responses. Subjects with Addison's disease, Cushing's disease or other diseases of the adrenal cortex likely to affect hormonal/neuroendocrine status. Subjects with current major depressive disorder, bipolar or post\-traumatic stress disorder as these disorders are associated with characteristic changes in stress response. Subjects receiving synthetic glucocorticoid therapy, any exogenous steroid therapy within one month of test session.
- •Subjects taking any psychotropic medications, including SSRI's or other antidepressants, opiates or opiate antagonists as these medicines may affect the test response. Subjects with any acute illness or fever.
- •\- positive urine tests indicating abuse of any abuse or stimulant.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparing effect of oxytocin versus oxytocin-propranolol combination on labor progressio]nduction and Promotion of labor.Spontaneous vertex deliveryIRCT2016092629983N1Gorgan Congenital malformations research center, Golestan University of Medical Sciences,Gorgan, Ira130
Completed
Phase 2
Comparing the effect of oxytocin alone versus oxytocin plus intravenous and oral propranolol on labor progressioIRCT2016103012789N13Vice Chancellor for Research of Kurdistan University of Medical Sciences123
Not yet recruiting
Not Applicable
An investigation of the effects of oxytocin on communicatiosociaal gedragn.v.t.NL-OMON35456niversitair Medisch Centrum Sint Radboud80
Completed
Not Applicable
Effects of Oxytocin on Uterine Atonyterine Atony after Cesarean Delivery.Atony of uterusIRCT2015020921015N1Medical School, Zahedan University of Medical sciences150
Not yet recruiting
Phase 4
Evaluation of the effects of oxytocin in patients with schizophreniaSchizophreniaObesityHealthy volunteersM01.774.500RBR-4yr9mtFaculdade de Medicina de Ribeirão Preto